NOVEL MATRICELLULAR SERUM MARKERS PREDICT LIVER FIBROSIS AND FIBROGENESIS IN PATIENTS WITH NAFLD UNDERGOING BARIATRIC SURGERY

被引：0
|
作者：
Surabattula, Rambabu [1 ]
Lassen, Pierre Bel [2 ,3 ]
Myneni, Sudharani [1 ]
Aron-Wisnewsky, Judith [2 ,3 ]
Genser, Laurent [3 ]
Zucker, Jean-Daniel [2 ]
Clement, Karine [2 ,3 ]
Schuppan, Detlef [1 ,4 ]
机构：
[1] Univ Med Ctr Mainz, Mainz, Germany
[2] Sorbonne Univ, Paris, France
[3] Hop La Pitie Salpetriere, Paris, France
[4] Harvard Med Sch, Boston, MA 02115 USA
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2085-A
引用
收藏
页码：S854 / S854
页数：1
相关论文
共 50 条
  • [41] Serum thrombospondin-2 and insulin -like growth factor binding protein 7 predict liver fibrosis and fibrosis regression in patients with MASLD post bariatric surgery
    Surabattula, Rambabu
    Lassen, Pierre Bel
    Myneni, Sudha Rani
    Judith, Aron-Wisnewsky
    Genser, Laurent
    Zucker, Jean-Daniel
    Clement, Karine
    Schuppan, Detlef
    JOURNAL OF HEPATOLOGY, 2024, 80 : S585 - S585
  • [42] A biomarker of fibrosis resolution, CTX-III, increases after bariatric surgery in early NAFLD patients with histological liver improvements
    Lonsmann, Ida
    Pedersen, Julie Steen
    Karsdal, Morten
    Ertle, Judith
    Schoelch, Corinna
    Leeming, Diana
    Bendtsen, Flemming
    JOURNAL OF HEPATOLOGY, 2023, 78 : S723 - S723
  • [43] Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients
    Nielsen, Mette Juul
    Villesen, Ida Falk
    Gudmann, Natasja Staehr
    Leeming, Diana Julie
    Krag, Aleksander
    Karsdal, Morten Asser
    Zimmermann, Tim
    Schuppan, Detlef
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [44] Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients
    Mette Juul Nielsen
    Ida Falk Villesen
    Natasja Stæhr Gudmann
    Diana Julie Leeming
    Aleksander Krag
    Morten Asser Karsdal
    Tim Zimmermann
    Detlef Schuppan
    Scientific Reports, 9
  • [45] IMPROVEMENT IN LIVER FIBROSIS AND SURROGATE MARKERS OF NAFLD WITH ENDOSCOPIC BARIATRIC THERAPIES: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Kumar, Vishnu Charan Suresh
    Subedi, Abinash
    Pemmasani, Gayatri
    Nasr, Dayana
    Aswath, Ganesh
    Sapkota, Bishnu
    Popov, Violeta
    GASTROENTEROLOGY, 2023, 164 (06) : S714 - S714
  • [46] SERUM HEPCIDIN LEVELS IN THE MORBIDLY OBESE PATIENTS UNDERGOING BARIATRIC SURGERY
    Vuppalanchi, R.
    Konrad, R.
    Chalasani, N.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S524 - S524
  • [47] Direct serological markers of liver fibrogenesis improve the diagnostic accuracy of indirect markers for liver fibrosis in chronic hepatitis C patients
    Nuñez, Oscar
    Martin, Maria Angeles
    Lorente, Raquel
    Senosiain, Maria
    Matilla, Ana
    Salinero, Emilio
    Catalina, Maria Vega
    Salcedo, Magdalena
    Muñoz, Maria Angeles
    Clemente, Gerardo
    HEPATOLOGY, 2006, 44 (04) : 273A - 273A
  • [48] Histological findings and NAFLD/NASH Status in liver biopsies of patients subjected to bariatric surgery
    Malucelli, Marielle
    Strobel, Rodrigo
    Ivantes, Claudia
    Sakamoto, Danielle
    Duarte, Marcio Luis
    Pedroso, Maria Lucia Alves
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2024, 68 (01):
  • [49] Stage of fibrosis is not a predictive determinant of weight loss in patients undergoing bariatric surgery
    Brol, Maximilian Joseph
    Drebber, Uta
    Yu, Xiaojie
    Schierwagen, Robert
    Gu, Wenyi
    Plamper, Andreas
    Klein, Sabine
    Odenthal, Margarete
    Uschner, Frank Erhard
    Praktiknjo, Michael
    Trebicka, Jonel
    Rheinwalt, Karl Peter
    SURGERY FOR OBESITY AND RELATED DISEASES, 2024, 20 (08) : 759 - 766
  • [50] Sleep apnea and liver function levels in patients undergoing bariatric surgery
    Waldo, B
    Herdegen, J
    Mikolaitis, S
    Madura, J
    Demeo, M
    OBESITY RESEARCH, 2003, 11 : A62 - A62
12345